166 related articles for article (PubMed ID: 37987379)
1. Application of Precision Medicine Concepts in Ambulatory Antibiotic Management of Acute Pyelonephritis.
Pizzuti M; Tsai YV; Winders HR; Bookstaver PB; Al-Hasan MN
Pharmacy (Basel); 2023 Oct; 11(6):. PubMed ID: 37987379
[TBL] [Abstract][Full Text] [Related]
2. A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis.
Bosch-Nicolau P; Falcó V; Viñado B; Andreu A; Len O; Almirante B; Pigrau C
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971876
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis.
Talan DA; Krishnadasan A; Abrahamian FM; Stamm WE; Moran GJ;
Clin Infect Dis; 2008 Nov; 47(9):1150-8. PubMed ID: 18808361
[TBL] [Abstract][Full Text] [Related]
4. A multicenter analysis of trends in resistance in urinary Enterobacterales isolates from ambulatory patients in the United States: 2011-2020.
Dunne MW; Aronin SI; Yu KC; Watts JA; Gupta V
BMC Infect Dis; 2022 Feb; 22(1):194. PubMed ID: 35227203
[TBL] [Abstract][Full Text] [Related]
5. Fluoroquinolones and resistance in the treatment of uncomplicated urinary tract infection.
Hooton TM
Int J Antimicrob Agents; 2003 Oct; 22 Suppl 2():65-72. PubMed ID: 14527774
[TBL] [Abstract][Full Text] [Related]
6. Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department Antibiogram.
Hines MC; Al-Salamah T; Heil EL; Mallemat H; Witting MD; Johnson JK; Winters ME; Hayes BD
J Emerg Med; 2015 Dec; 49(6):998-1003. PubMed ID: 26281821
[TBL] [Abstract][Full Text] [Related]
7. [National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients].
Wagenlehner FM; Schmiemann G; Hoyme U; Fünfstück R; Hummers-Pradier E; Kaase M; Kniehl E; Selbach I; Sester U; Vahlensieck W; Watermann D; Naber KG
Urologe A; 2011 Feb; 50(2):153-69. PubMed ID: 21312083
[TBL] [Abstract][Full Text] [Related]
8. A Seven-Day Course of TMP-SMX May Be as Effective as a Seven-Day Course of Ciprofloxacin for the Treatment of Pyelonephritis.
Fox MT; Melia MT; Same RG; Conley AT; Tamma PD
Am J Med; 2017 Jul; 130(7):842-845. PubMed ID: 28216442
[TBL] [Abstract][Full Text] [Related]
9. Change of antimicrobial susceptibility among Escherichia coli strains isolated from female patients with community-onset acute pyelonephritis.
Lim SK; Park IW; Lee WG; Kim HK; Choi YH
Yonsei Med J; 2012 Jan; 53(1):164-71. PubMed ID: 22187248
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
Etienne M; Van Elslande H; Choplin-Renard J; Pestel-Caron M; Caron F
Med Mal Infect; 2014 May; 44(5):217-22. PubMed ID: 24787633
[TBL] [Abstract][Full Text] [Related]
11. Addressing antibiotic resistance.
Gupta K
Dis Mon; 2003 Feb; 49(2):99-110. PubMed ID: 12601340
[TBL] [Abstract][Full Text] [Related]
12. Addressing antibiotic resistance.
Gupta K
Am J Med; 2002 Jul; 113 Suppl 1A():29S-34S. PubMed ID: 12113869
[TBL] [Abstract][Full Text] [Related]
13. Risk of antibiotic treatment failure in premenopausal women with uncomplicated urinary tract infection.
Butler AM; Durkin MJ; Keller MR; Ma Y; Dharnidharka VR; Powderly WG; Olsen MA
Pharmacoepidemiol Drug Saf; 2021 Oct; 30(10):1360-1370. PubMed ID: 33783918
[TBL] [Abstract][Full Text] [Related]
14. Outpatient antibiogram and predictors of ciprofloxacin and trimethoprim-sulfamethoxazole resistant urinary tract infections.
Valentine-King M; Zoorob R; Grigoryan L; Trautner B
Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36944052
[TBL] [Abstract][Full Text] [Related]
15. Predictors of receipt of a fluoroquinolone versus trimethoprim-sulfamethoxazole for treatment of acute pyelonephritis in women in Manitoba, Canada.
Carrie AG; Metge CJ; Collins DM; Harding GK; Zhanel GG
Pharmacoepidemiol Drug Saf; 2004 Dec; 13(12):863-70. PubMed ID: 15386718
[TBL] [Abstract][Full Text] [Related]
16. Regional Differences in Antibiotic-resistant Enterobacterales Urine Isolates in the United States: 2018-2020.
Aronin SI; Gupta V; Dunne MW; Watts JA; Yu KC
Int J Infect Dis; 2022 Jun; 119():142-145. PubMed ID: 35364285
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for quinolone-resistance in women presenting with Escherichia coli acute pyelonephritis.
Bedoin M; Cazorla C; Lucht F; Berthelot P; Boyer M; Carricajo A; Guérin T; Viallon A
Med Mal Infect; 2014 May; 44(5):206-16. PubMed ID: 24794820
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic resistance in isolates recovered from women with community-acquired urinary tract infections presenting to a tertiary care emergency department.
Filiatrault L; McKay RM; Patrick DM; Roscoe DL; Quan G; Brubacher J; Collins KM
CJEM; 2012 Sep; 14(5):295-305. PubMed ID: 22967697
[TBL] [Abstract][Full Text] [Related]
19. Use of gentamicin for women with community-acquired uncomplicated acute pyelonephritis caused by gentamicin-susceptible or -resistant Escherichia coli: 10-year experience.
Wie SH; Kim HW; Chang UI
Microb Drug Resist; 2013 Aug; 19(4):316-22. PubMed ID: 23473263
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Trimethoprim and Sulfamethoxazole-Resistant Escherichia Coli in ED Patients with Urinary Tract Infections.
Wesolek JL; Wu JY; Smalley CM; Wang L; Campbell MJ
Am J Emerg Med; 2022 Jun; 56():178-182. PubMed ID: 35405469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
